About the fund

The Agape Fund allocates philanthropic capital to advance medical research in neurodegenerative diseases and improve care delivery systems for the neurodivergent community. We are a mission-driven organization dedicated to supporting the most impactful, evidence-based initiatives that serve individuals and families across this spectrum of need.

Our work spans funding breakthrough research, designing and delivering inclusive therapy programs, and launching pilot studies that test and scale innovative models of care. We believe in cross-sector collaboration, scientific rigor, and community engagement as essential tools for creating long-term, systemic impact.

The Agape Fund is a 501(c)(3) public charity (EIN: 99-4102585), classified under IRS Section 170(b)(1)(A)(vi). We also operate a Donor-Advised Fund (DAF) platform to enable aligned philanthropists to participate in our mission and co-invest in our grantmaking efforts.